Lv3
210 积分 2026-03-23 加入
Efficacy and safety of SHR-1701 combined with chemoradiotherapy as neoadjuvant treatment for locally advanced rectal cancer
8天前
已完结
The Efficacy and Safety of Tislelizumab plus Anlotinib as First-line Treatment in Advanced Pulmonary Sarcomatoid Carcinoma: A Single-Arm Phase II Trial
13天前
已完结
Analysis and prediction of pathological risk factors for lung cancer by plasma metabolomics
16天前
已完结
Bronchial Arterial Chemoembolization Combined with Tislelizumab for Non–Small Cell Lung Cancer: An Exploratory, Prospective, Single-Arm, Phase II Trial
24天前
已完结
Precision medicine in Salivary Gland Carcinoma: Insights from breast and prostate cancer
28天前
已完结
Adjuvant atezolizumab after adjuvant chemotherapy inresected stage IB-IllA non-small-cell lung cancer(IMpowero10): a randomised, multicentre, open-label,phase 3trial
1个月前
已完结
Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trial
1个月前
已完结
International Expert Recommendations for the Diagnosis and Treatment of Malignant Histiocytic Neoplasms
4个月前
已关闭
Across borders and histologies: Rethinking endpoints for vascular sarcoma trials
5个月前
已完结
皖公网安备34019202002308
